Eliot Engel actually said...

the Part D MTM model will give prescription drug plans stronger incentives and flexibility to improve prescription drug safety and efficacy.

Thank you very much, Mr. Chairman. Thank you for calling this markup. Let me say that I agree with every word you said.

I have always felt that we didn't do enough in terms of education, and in terms of that side of it.

We can't continue like this. I mean, we have got to do a better job of educating people.